Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 Isolates

Novel viral vectors that are able to induce both strong and long-lasting immune responses may be required as effective vaccines for human immunodeficiency virus type 1 (HIV-1) infection. Our previous experiments with a replication-competent vaccine strain-based rabies virus (RV) expressing HIV-1 env...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	McGettigan, James P., Foley, Heather D., Belyakov, Igor M., Berzofsky, Jay A., Pomerantz, Roger J., Schnell, Matthias J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114191/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11287595/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.9.4430-4434.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!